Consideration of Comorbidities in Treatment Choice for Patients with Type 2 Diabetes (T2DM)

被引：0
作者：
Ritchey, Mary E.
Engel, Samuel S.
Liu, Zhiwen
Ntabadde, Catherine
Senderak, Michael
Shankar, Ravi
Qiu, Ying
Radican, Larry
Rajpathak, Swapnil
Brodovicz, Kimberly G.
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2513-PO
引用
收藏
页码：A636 / A636
页数：1
相关论文
共 50 条
  • [21] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
    Kosmalski, M.
    Drozdowska, A.
    Sliwinska, A.
    Drzewoski, J.
    ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
  • [22] Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program
    Mahaffey, Kenneth W.
    Ianus, Juliana
    Damaraju, C. V.
    Neal, Bruce
    De Zeeuw, Dick
    Fulcher, Greg
    Pfeifer, Michael
    Matthews, David R.
    DIABETES, 2019, 68
  • [23] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
    Martin, Silas C.
    Henk, Henry J.
    Chow, Wing
    DIABETES, 2014, 63 : A307 - A307
  • [24] Effect of empagliflozin (EMPA) on bone fractures in patients with type 2 diabetes (T2DM)
    Kohler, S.
    Kaspers, S.
    Salsali, A.
    Zeller, C.
    Woerle, H. -J.
    DIABETOLOGIA, 2016, 59 : S26 - S26
  • [25] Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM
    Wu, Xu
    Li, Yashan
    Man, Baohua
    Li, Dexuan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1445 - 1451
  • [26] MobiDiabet: Mobile Telemonitoring System for Patients with Type 2 Diabetes Mellitus (T2DM)
    Alcala Juarez, Anakaren
    Hernandez Villegas, Manuel Alejandro
    Dominguez, Eduardo Lopez
    Hernandez Velazquez, Yesenia
    Dominguez Isidro, Saul
    Ovando Diego, Liliana
    Hernandez Sanchez, Olivia
    De La Calleja, Jorge
    Pomares Hernandez, Saul Eduardo
    Medina Nieto, Maria Auxilio
    APPLIED SCIENCES-BASEL, 2020, 10 (22): : 1 - 36
  • [27] Use of sitagliptin in patients with type 2 diabetes (T2DM) and renal insufficiency (RI)
    Scott, Russell
    Hartley, Paul
    Luo, Edmund
    Yee, Jacqueline
    Davies, Michael
    Ferreira, Juan Camilo Arjona
    Williams-Herman, Debora
    DIABETES, 2006, 55 : A462 - A462
  • [28] Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Renal Impairment (RI)
    Barnett, Anthony H.
    Mithal, Ambrish
    Manassie, Jenny
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2013, 62 : A286 - A286
  • [29] Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM)
    Arun Thulasi
    Vinod Kumar
    Aarti Jagannathan
    Praveen Angadi
    Kundapur Umamaheswar
    Nagarathna Raghuram
    Journal of Religion and Health, 2022, 61 : 1951 - 1965
  • [30] Pioglitazone (PIO) enhances insulin sensitivity (IS) in patients with type 2 diabetes (T2DM)
    Johns, D
    Herz, M
    Tan, MH
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    DIABETES, 2002, 51 : A102 - A102
12345